Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 20;10(6):1429.
doi: 10.3390/foods10061429.

Human Milk Oligosaccharides (HMOs) and Infant Microbiota: A Scoping Review

Cristina Sánchez  1 , Cristina Fente  2 , Patricia Regal  2 , Alexandre Lamas  2 , María Paz Lorenzo  1
Affiliations

Human Milk Oligosaccharides (HMOs) and Infant Microbiota: A Scoping Review

Cristina Sánchez et al. Foods. .

Abstract

Human milk oligosaccharides (HMOs) are the third most abundant solid component of breast milk. However, the newborn cannot assimilate them as nutrients. They are recognized prebiotic agents (the first in the newborn diet) that stimulate the growth of beneficial microorganisms, mainly the genus Bifidobacterium, dominant in the gut of breastfed infants. The structures of the oligosaccharides vary mainly according to maternal genetics, but also other maternal factors such as parity and mode of delivery, age, diet, and nutritional status or even geographic location and seasonality cause different breast milk oligosaccharides profiles. Differences in the profiles of HMO have been linked to breast milk microbiota and gut microbial colonization of babies. Here, we provide a review of the scope of reports on associations between HMOs and the infant gut microbiota to assess the impact of HMO composition.

Keywords: breast milk; breastfeeding; human milk oligosaccharide; infant gut microbiota; microbiome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram describing study selection process.
See this image and copyright information in PMC

References

    1. Collective G.B. UNICEF Nurturing the Health and Wealth of Nations: The Investment Case for Breastfeeding. World Health Organization; Geneva, Switzerland: 2017.
    1. Chouraqui J.-P. Does the contribution of human milk oligosaccharides to the beneficial effects of breast milk allow us to hope for an improvement in infant formulas? Crit. Rev. Food Sci. Nutr. 2020:1–12. doi: 10.1080/10408398.2020.1761772. - DOI - PubMed
    1. Bode L. The functional biology of human milk oligosaccharides. Early Hum. Dev. 2015;91:619–622. doi: 10.1016/j.earlhumdev.2015.09.001. - DOI - PubMed
    1. Balogh R., Jankovics P., Béni S. Qualitative and quantitative analysis of N-acetyllactosamine and lacto-N-biose, the two major building blocks of human milk oligosaccharides in human milk samples by high-performance liquid chromatography–tandem mass spectrometry using a porous graphitic. J. Chromatogr. A. 2015;1422:140–146. doi: 10.1016/j.chroma.2015.10.006. - DOI - PubMed
    1. Vandenplas Y., Berger B., Carnielli V.P., Ksiazyk J., Lagström H., Sanchez Luna M., Migacheva N., Mosselmans J.-M., Picaud J.-C., Possner M. Human milk oligosaccharides: 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients. 2018;10:1161. doi: 10.3390/nu10091161. - DOI - PMC - PubMed

Publication types

LinkOut - more resources